Report #2862039

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Recovered

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Deathly ill; This serious case was reported by a consumer via interactive digital media and described the occurrence of unwell in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced unwell (Verbatim: Deathly ill) (serious criteria other: Serious as per reporter). The outcome of the unwell was resolved (duration 3 weeks). The reporter considered the unwell to be related to Shingrix. The company considered the unwell to be unrelated to Shingrix. Additional Information: GSK Receipt Date:07-SEP-2025 This case was reported by a patient via interactive digital media. The patient took the two Shingrix shots and after the 2nd shot she was deathly ill for 3 weeks. It was horrible experience.; Sender's Comments: A case of Malaise, unknown time after receiving Shingrix in a adult female patient. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.